PlainPharmaWatch

CMS Open Payments · Tool

Solco Biomedical Corporation vs Avantec Vascular Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Avantec Vascular Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 5,355, versus 5,197 for the other company. Its single largest recorded recipient represents 72.8% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Solco Biomedical Corporation
HHI 5,197 · top recipient 68.9%
Ranked #332 of 1,838 companies by HHI
Avantec Vascular Corporation
HHI 5,355 · top recipient 72.8%
Ranked #310 of 1,838 companies by HHI

Payment Overview

Total Payments
$18.0K
% of Industry
0.0%
Transactions
11
Avg per Transaction
$1.6K
Recipients
11
Avg per Recipient
$1.6K
Payment Types
2
Top Payment Type
Consulting Fee
View full profile →
Total Payments
$17.9K
% of Industry
0.0%
Transactions
48
Avg per Transaction
$371.90
Recipients
48
Avg per Recipient
$371.90
Payment Types
2
Top Payment Type
Consulting Fee
View full profile →

Highlighted values indicate the higher figure for each metric.

Total payments compared

Solco Biomedical Corporation vs Avantec Vascular Corporation - total reported payments in CMS Open Payments PY2024

Solco Biomedical Corporation$18.0KAvantec Vascular Corporation$17.9K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Solco Biomedical Corporation

Consulting Fee $11.4K

63.3%

Travel and Lodging $6.6K

36.7%

Avantec Vascular Corporation

Consulting Fee $13.0K

72.8%

Food and Beverage $4.9K

27.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Solco Biomedical Corporation

  1. 1

    MICHAEL OH

    $12,400.00 · 7 txns

  2. 2

    RICHARD DAVIS

    $3,600.00 · 1 txns

  3. 3

    Hooman Melamed

    $1,100.00 · 1 txns

  4. 4

    PAUL SALINAS

    $600.00 · 1 txns

  5. 5

    KEVIN YOO

    $300.00 · 1 txns

Avantec Vascular Corporation

  1. 1

    SIRISH KISHORE

    $13,000.00 · 4 txns

  2. 2

    Erin Murphy

    $660.81 · 4 txns

  3. 3

    CRAIG WALKER

    $592.42 · 5 txns

  4. 4

    GLORIA SALAZAR

    $355.61 · 2 txns

  5. 5

    SREEKUMAR MADASSERY

    $346.21 · 1 txns

Summary Comparison

Metric Solco Biomedical Corporation Avantec Vascular Corporation
Total Payments $18.0K $17.9K
% of Industry Total 0.0% 0.0%
Transaction Count 11 48
Avg per Transaction $1.6K $371.90
Recipient Count 11 48
Avg per Recipient $1.6K $371.90
Payment Type Count 2 2
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Compiled from official public sources by the publisher.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.